{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:05:03Z","timestamp":1784639103601,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002562","name":"Sunchon National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002562","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Toxicology and Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.etap.2026.105095","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:34:08Z","timestamp":1783604048000},"page":"105095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Physiologically based pharmacokinetic modeling of caffeine in patients with liver cirrhosis: Implications for exposure-guided dose adjustment"],"prefix":"10.1016","volume":"125","author":[{"given":"Se-In","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7515-0631","authenticated-orcid":false,"given":"Seung-Hyun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.etap.2026.105095_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s002280050735","article-title":"The effects of acute falciparum malaria on the disposition of caffeine and the comparison of saliva and plasma-derived pharmacokinetic parameters in adult Nigerians","volume":"56","author":"Akinyinka","year":"2000","journal-title":"E J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2026.105095_bib2","series-title":"The Link Between Coffee and Health","first-page":"569","article-title":"Inter-individual Differences in Response to Caffeine","author":"Baron","year":"2025"},{"key":"10.1016\/j.etap.2026.105095_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/j.1552-4604.1984.tb02774.x","article-title":"The excretion of caffeine in the semen of men: pharmacokinetics and comparison of the concentrations in blood and semen","volume":"24","author":"Beach","year":"1984","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2026.105095_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00613933","article-title":"The absolute bioavailability of caffeine in man","volume":"24","author":"Blanchard","year":"1983","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2026.105095_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/clpt.1982.132","article-title":"Caffeine disposition after oral doses","volume":"32","author":"Bonati","year":"1982","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.etap.2026.105095_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00003088-200039020-00004","article-title":"Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine and Medications","volume":"39","author":"Carrillo","year":"2000","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.etap.2026.105095_bib7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/clpt.1990.66","article-title":"Dose-dependent pharmacokinetics of caffeine in humans: relevance as a test of quantitative liver function","volume":"47","author":"Cheng","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.etap.2026.105095_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/beverages11010018","article-title":"Caffeinated Beverages\u2014Unveiling Their Impact on Human Health","volume":"11","author":"\u010ci\u017em\u00e1rov\u00e1","year":"2025","journal-title":"Beverages"},{"key":"10.1016\/j.etap.2026.105095_bib9","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1002\/jcph.2266","article-title":"Use of physiologically based pharmacokinetic modeling for hepatically cleared drugs in pregnancy: regulatory perspective","volume":"63","author":"Coppola","year":"2023","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2026.105095_bib10","series-title":"Evaluation of the Effect of Metabolism and Transporters on Drug Pharmacokinetics and Pharmacodynamics Using PBPK Modeling","first-page":"121","author":"Darakjian","year":"2020"},{"key":"10.1016\/j.etap.2026.105095_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01308138","article-title":"Impaired elimination of caffeine in cirrhosis","volume":"25","author":"Desmond","year":"1980","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.etap.2026.105095_bib12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2165\/00003088-200847110-00005","article-title":"Physiology-Based Simulations of a Pathological Condition","volume":"47","author":"Edginton","year":"2008","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.etap.2026.105095_bib13","first-page":"4102","article-title":"Scientific Opinion on the safety of caffeine","volume":"13","author":"Efsa Panel on Dietetic Products","year":"2015","journal-title":"EFSA J."},{"key":"10.1016\/j.etap.2026.105095_bib14","doi-asserted-by":"crossref","first-page":"7156","DOI":"10.1021\/acs.jmedchem.1c00261","article-title":"The Medicinal Chemistry of Caffeine","volume":"64","author":"Faudone","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.etap.2026.105095_bib15","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3389\/fphar.2021.752826","article-title":"Pharmacokinetics of Caffeine: A Systematic Analysis of Reported Data for Application in Metabolic Phenotyping and Liver Function Testing","volume":"12","author":"Grzegorzewski","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.etap.2026.105095_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/18755453MTEyCOTgcx","article-title":"Metabolism and mechanism of human cytochrome P450 enzyme 1A2","volume":"22","author":"Guo","year":"2021","journal-title":"Curr. Drug. Metab."},{"key":"10.1016\/j.etap.2026.105095_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01736528","article-title":"Correlation of caffeine elimination and child's classification in liver cirrhosis","volume":"67","author":"Holstege","year":"1989","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.etap.2026.105095_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-026-05191-2","article-title":"Physiologically based pharmacokinetic modeling of immediate-release and extended-release formulations of doxazosin, an alpha-1 adrenergic receptor antagonist, with model simulations for patients with liver disease","author":"Jeong","year":"2026","journal-title":"Naunyn-Schmiede 's. Arch. Pharmacol."},{"key":"10.1016\/j.etap.2026.105095_bib19","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1016\/j.xphs.2022.08.035","article-title":"Physiologically Based Pharmacokinetic (PBPK) Modeling of Lornoxicam: Exploration of doses for CYP2C9 Genotypes and Patients with Cirrhosis","volume":"111","author":"Jeong","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.etap.2026.105095_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/jcph.70164","article-title":"Physiologically Based Pharmacokinetic Modeling of Lurasidone, an Antipsychotic Drug: Impact of CYP3A4 Polymorphisms and Hepatic Impairment on Exposure and Dose Optimization","volume":"66","author":"Jeong","year":"2026","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2026.105095_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/11318160-000000000-00000","article-title":"A Semi-Mechanistic Model to Predict the Effects of Liver Cirrhosis on Drug Clearance","volume":"49","author":"Johnson","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.etap.2026.105095_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5173(01)00958-9","article-title":"The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers","volume":"234","author":"Kamimori","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.etap.2026.105095_bib23","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1124\/dmd.119.087718","article-title":"Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1\/1A2 and Cyp1a1\/Cyp1a2 Knockout Mice","volume":"47","author":"Kapelyukh","year":"2019","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.etap.2026.105095_bib24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/j.1552-4604.1997.tb04356.x","article-title":"Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans","volume":"37","author":"Kaplan","year":"1997","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2026.105095_bib25","first-page":"529","article-title":"Factors affecting coffee intake in Korean adults","volume":"21","author":"Kim","year":"2020","journal-title":"J. Korea Acad. -Ind. Coop. Soc."},{"key":"10.1016\/j.etap.2026.105095_bib26","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1111\/bcp.13389","article-title":"Comparison of caffeine disposition following administration by oral solution (energy drink) and inspired powder (AeroShot) in human subjects","volume":"83","author":"Laizure","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2026.105095_bib27","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/jcph.70079","article-title":"Precision Pharmacokinetics of Quetiapine: A Physiologically Based Model Incorporating Liver Cirrhosis and CYP3A4 Polymorphisms","volume":"65","author":"Lee","year":"2025","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2026.105095_bib28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.fct.2013.10.042","article-title":"Beverage caffeine intakes in the U.S","volume":"63","author":"Mitchell","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.etap.2026.105095_bib29","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.2042-7158.2011.01326.x","article-title":"Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics","volume":"63","author":"Perera","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.etap.2026.105095_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bpg.2011.02.009","article-title":"Liver cirrhosis","volume":"25","author":"Pinzani","year":"2011","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.etap.2026.105095_bib31","series-title":"Handbook of Substance Misuse and Addictions: From Biology to Public Health","first-page":"1535","article-title":"Caffeine Consumption over Time","author":"Quadra","year":"2022"},{"key":"10.1016\/j.etap.2026.105095_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2019.113343","article-title":"A global trend of caffeine consumption over time and related-environmental impacts","volume":"256","author":"Quadra","year":"2020","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.etap.2026.105095_bib33","article-title":"Pharmacology of caffeine and its effects on the human body","volume":"10","author":"Reddy","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.etap.2026.105095_bib34","series-title":"Nutraceuticals (Second Edition)","first-page":"501","article-title":"Caffeine: an evaluation of the safety database","author":"Roberts","year":"2021"},{"key":"10.1016\/j.etap.2026.105095_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1467-3010.2007.00665.x","article-title":"The impact of caffeine on mood, cognitive function, performance and hydration: a review of benefits and risks","volume":"33","author":"Ruxton","year":"2008","journal-title":"Nutr. Bull."},{"key":"10.1016\/j.etap.2026.105095_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/jcr.2017.0025","article-title":"A randomized, two-way crossover study to evaluate the pharmacokinetics of caffeine delivered using caffeinated chewing gum versus a marketed caffeinated beverage in healthy adult volunteers","volume":"7","author":"Sadek","year":"2017","journal-title":"J. Caffeine Res."},{"key":"10.1016\/j.etap.2026.105095_bib37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2710.1991.tb00316.x","article-title":"Pharmacokinetics of intravenous caffeine in critically ill patients","volume":"16","author":"S\u00e1nchez-Alcaraz","year":"1991","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.etap.2026.105095_bib38","first-page":"101","article-title":"Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: Caffeine)","volume":"30","author":"Smetanova","year":"2009","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.etap.2026.105095_bib39","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/ajcp\/73.3.390","article-title":"Serum Caffeine Half-lives: Healthy Subjects vs. Patients Having Alcoholic Hepatic Disease","volume":"73","author":"Statland","year":"1980","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.etap.2026.105095_bib40","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/0006-2952(94)90304-2","article-title":"Caffeine metabolism by human hepatic cytochromes p450: Contributions of 1A2, 2E1 and 3A isoforms","volume":"47","author":"Tassaneeyakul","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.etap.2026.105095_bib41","article-title":"Pharmacokinetics of caffeine following a single administration of coffee enema versus oral coffee consumption in healthy male subjects","volume":"2013","author":"Teekachunhatean","year":"2013","journal-title":"Int. Sch. Res. Not."},{"key":"10.1016\/j.etap.2026.105095_bib42","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.1152\/ajpendo.00494.2003","article-title":"Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics","volume":"287","author":"Tietge","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.etap.2026.105095_bib43","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bbalip.2016.04.013","article-title":"Liver disease alters high-density lipoprotein composition, metabolism and function","volume":"1861","author":"Trieb","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"10.1016\/j.etap.2026.105095_bib44","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","article-title":"Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction","volume":"64","author":"Verbeeck","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2026.105095_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.113629","article-title":"Trends of caffeine intake from food and beverage among Chinese adults: 2004\u20132018","volume":"173","author":"Ye","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.etap.2026.105095_bib46","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4163\/jnh.2016.49.5.367","article-title":"Relationships between job stress and caffeine intake in industrial workers","volume":"49","author":"Yim","year":"2016","journal-title":"J. Nutr. Health"}],"container-title":["Environmental Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668926001730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668926001730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:46:29Z","timestamp":1784637989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1382668926001730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":46,"alternative-id":["S1382668926001730"],"URL":"https:\/\/doi.org\/10.1016\/j.etap.2026.105095","relation":{},"ISSN":["1382-6689"],"issn-type":[{"value":"1382-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physiologically based pharmacokinetic modeling of caffeine in patients with liver cirrhosis: Implications for exposure-guided dose adjustment","name":"articletitle","label":"Article Title"},{"value":"Environmental Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.etap.2026.105095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105095"}}